OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverage
Kshitij Wagh, Michael S. Seaman
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 164-170
Open Access | Times Cited: 13
Kshitij Wagh, Michael S. Seaman
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 164-170
Open Access | Times Cited: 13
Showing 13 citing articles:
Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies
Jyoti Sutar, Priyanka Jayal, Ranajoy Mullick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Jyoti Sutar, Priyanka Jayal, Ranajoy Mullick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Immune-mediated strategies to solving the HIV reservoir problem
Deanna A. Kulpa, Mirko Paiardini, Guido Silvestri
Nature reviews. Immunology (2025)
Closed Access
Deanna A. Kulpa, Mirko Paiardini, Guido Silvestri
Nature reviews. Immunology (2025)
Closed Access
Combinatorial Fc modifications for complementary antibody functionality
Yannic C. Bartsch, Nicholas E. Webb, Eleanor Burgess, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Yannic C. Bartsch, Nicholas E. Webb, Eleanor Burgess, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Subcutaneous Liposomal Delivery Improves Monoclonal Antibody Pharmacokinetics in vivo
Maryam Karimi, Arash Aslanabadi, Ben Atkinson, et al.
Acta Biomaterialia (2025)
Closed Access
Maryam Karimi, Arash Aslanabadi, Ben Atkinson, et al.
Acta Biomaterialia (2025)
Closed Access
Preventing breast milk HIV transmission using broadly neutralizing monoclonal antibodies: One size does not fit all
Philippe Van de Perre, Gabriella Scarlatti, Penny L. Moore, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 2
Philippe Van de Perre, Gabriella Scarlatti, Penny L. Moore, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 2
Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses
Xiaoli Wu, Abulimiti Moming, Yanfang Zhang, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 6, pp. e0012216-e0012216
Open Access | Times Cited: 2
Xiaoli Wu, Abulimiti Moming, Yanfang Zhang, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 6, pp. e0012216-e0012216
Open Access | Times Cited: 2
A Comprehensive Engineering Strategy Improves Potency and Manufacturability of a Near Pan-neutralizing Antibody Against HIV
Mohammad M. Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
(2024)
Closed Access | Times Cited: 1
Mohammad M. Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
(2024)
Closed Access | Times Cited: 1
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
Rajesh P. Ringe, Philippe Colin, Gabriel Ozorowski, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011601-e1011601
Open Access | Times Cited: 3
Rajesh P. Ringe, Philippe Colin, Gabriel Ozorowski, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011601-e1011601
Open Access | Times Cited: 3
Macrophage- and CD4+T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
Christina B. Karsten, Falk F. R. Buettner, Samanta Cajic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Christina B. Karsten, Falk F. R. Buettner, Samanta Cajic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Justin Harper, Michael R. Betts, Mathias Lichterfeld, et al.
Pathogens and Immunity (2024) Vol. 8, Iss. 2, pp. 115-157
Open Access
Justin Harper, Michael R. Betts, Mathias Lichterfeld, et al.
Pathogens and Immunity (2024) Vol. 8, Iss. 2, pp. 115-157
Open Access
Erratum to: Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Justiin Harper, Michael R. Betts, Mathias Lichterfeld, et al.
Pathogens and Immunity (2024) Vol. 8, Iss. 2, pp. 179-222
Open Access
Justiin Harper, Michael R. Betts, Mathias Lichterfeld, et al.
Pathogens and Immunity (2024) Vol. 8, Iss. 2, pp. 179-222
Open Access
The XbnAb Cohort: 304 people with broadly neutralizing antibody activity to HIV-1
Chloé Pasin, Peter Rusert, Daniel Schmidt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Chloé Pasin, Peter Rusert, Daniel Schmidt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
Rajesh P. Ringe, Philippe Colin, Gabriel Ozorowski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Rajesh P. Ringe, Philippe Colin, Gabriel Ozorowski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
